Compare KURA & AVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KURA | AVO |
|---|---|---|
| Founded | 2014 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2015 | 2020 |
| Metric | KURA | AVO |
|---|---|---|
| Price | $10.91 | $12.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 1 |
| Target Price | ★ $25.56 | $17.00 |
| AVG Volume (30 Days) | ★ 1.8M | 706.7K |
| Earning Date | 05-12-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.92 |
| EPS | N/A | ★ N/A |
| Revenue | $67,482,000.00 | ★ $1,391,200,000.00 |
| Revenue This Year | $28.28 | N/A |
| Revenue Next Year | $106.37 | $3.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 25.24 | 12.68 |
| 52 Week Low | $7.36 | $10.07 |
| 52 Week High | $13.90 | $15.53 |
| Indicator | KURA | AVO |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 48.38 |
| Support Level | $8.45 | $12.20 |
| Resistance Level | $11.40 | $13.37 |
| Average True Range (ATR) | 0.48 | 0.46 |
| MACD | -0.18 | -0.01 |
| Stochastic Oscillator | 6.75 | 26.11 |
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.